New positive data on old drugs: Digitalis reduces heart failure events

AI Summary

Recent studies have demonstrated that digitalis glycosides considerably reduce heart failure events in patients, with findings presented at a major congress in Europe. This reaffirms the utility of established medications in managing heart failure treatment.

Analyses supporting the use of digitalis glycosides in patients with heart failure were presented in a Late-Breaking Science session today at Heart Failure 2026, the annual congress of the Heart Failure Association of the European Society of Cardiology.